Related Experiment Video
Updated: Sep 11, 2025
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Epitope Conservation of AZD5148, a Broadly Neutralizing Anti-Toxin B Monoclonal Antibody, Among Diverse and Global
Kelly Ann Mahool1, Emily Nguyen1, Victoria Godfrey2
1Bioinformatics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
Background:
Clostridioides difficile toxin B is a virulence factor for C. difficile infections and a clinically validated target for prevention of C. difficile infection recurrence. AZD5148 is a toxin B-neutralizing human monoclonal antibody that binds to an epitope on the toxin B glucosyltransferase domain. Herein, we aim to evaluate the conservation of this binding epitope using a collection of 9134 global C. difficile genomes obtained from a public repository to confirm that residues that are crucial for neutralization are conserved.
Methods:
Using isolates collected between 2015 and 2023 from 2 independent sources, we performed variant calling, sequence typing, and phylogenetic analysis. We tested in vitro neutralization of cytotoxicity by AZD5148 using 2 cell lines.
Results:
Herein, we showed that the AZD5148 epitope is highly conserved across all geographic regions and sequence types and has a higher average conservation frequency in its binding site (99.58%) when compared with bezlotoxumab (82.47%). AZD5148 also exhibited broad neutralization in vitro against 8 recently circulating ribotypes.
Conclusions:
Our comprehensive analysis of global sequences found the AZD5148 epitope to be highly conserved and thus unlikely to be affected by most genotypic variations in recently circulating C. difficile ribotypes and sequence types.
